Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

ELVN Enliven Therapeutics Inc

24,54

-0,87 (-3,42%)

22 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

null

Enliven Therapeutics (NASDAQ:ELVN)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Enliven Therapeutics Charts.

Enliven Therapeutics (NASDAQ:ELVN)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Enliven Therapeutics Charts.

News Enliven Therapeutics Inc

Form 144 - Report of proposed sale of securities
Freitag 15 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 15 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Mittwoch 13 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update
Mittwoch 13 November 2024 (1 Woche vor) • PR Newswire (US)

Enliven Therapeutics to Present at the Jefferies London Healthcare Conference
Donnerstag 7 November 2024 (2 Wochen vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 30 Oktober 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Donnerstag 24 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 22 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 22 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Weitere Enliven Therapeutics Inc News-Artikel

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen